Citation Impact
Citing Papers
Carboplatin dosage: prospective evaluation of a simple formula based on renal function.
1989 Standout
Pharmaceutical Particle Engineering via Spray Drying
2007 Standout
Population pharmacokinetics of the photodynamic therapy agent 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a in cancer patients.
2003
The effects of oxidative stress on female reproduction: a review
2012 Standout
Pharmacokinetic Study of Omeprazole in Elderly Healthy Volunteers
1992
Concurrent Cisplatin-Based Radiotherapy and Chemotherapy for Locally Advanced Cervical Cancer
1999 Standout
Polychlorinated Biphenyls (PCBs) and Human Health: An Update
1995
Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies
2005 Standout
The role of porphyrin chemistry in tumor imaging and photodynamic therapy
2010 Standout
Quinine pharmacokinetics in cerebral malaria: predicted plasma concentrations after rapid intravenous loading using a two-compartment model
1988
Valvular Heart Disease Associated with Fenfluramine–Phentermine
1997 Standout
Severe and complicated malaria
1990 Standout
pH-Related Changes in the Absorption of Dipyridamole in the Elderly
1994
The Phenomenon and Rationale of Marked Dependence of Drug Concentration on Blood Sampling Site
1989
Chloroqine Treatment of Severe Malaria in Children
1988
Risk of Infectious Complications in Patients Taking Glucocorticosteroids
1989 Standout
Spray-dryed bupivacaine-loaded microspheres: in vitro evaluation and biopharmaceutics of bupivacaine following brachial plexus administration in sheep
2002
Influence of maternal ingestion of aroclor 1254� (PCB) or firemaster BP-6� (PBB) on unstimulated and stimulated corticosterone levels in young rats
1992
Simple Methods for Estimation of Mean Residence Time and Steady-State Volume of Distribution from Continuous-Infusion Data
1991
Modification of Rectal Absorption of Morphine Hollow-Type Suppositories with a Combination of α‐Cyclodextrin and Viscosity-Enhancing Pol ysacc haride
1995
Age‐related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications
2003 Standout
Central nervous and cardiovascular effects of i.v. infusions of ropivacaine, bupivacaine and placebo in volunteers
1997 Standout
Carboplatin and etoposide pharmacokinetics in patients with testicular teratoma
1989
Radiosensitization by a new potent nucleoside analog: 1-(1′,3′,4′-trihydroxy-2′-butoxy)methyl-2-nitroimidazole(RP-343)
1993 StandoutNobel
Plasma free platinum pharmacokinetics in patients treated with high dose carboplatin
1987
Evaluation of Various Dissolution Media for Predicting In Vivo Performance of Class I and II Drugs
1998 Standout
Kinetics and Dynamics of Prednisolone*
1987
Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture
2006 Standout
Structure-antioxidant activity relationships of flavonoids and phenolic acids
1996 Standout
The biochemistry and medical significance of the flavonoids
2002 Standout
FIP Guidelines for Dissolution Testing of Solid Oral Products
2018
Continuous infusion carboplatin on a 21-day schedule: a phase I and pharmacokinetic study.
1991
Polychlorinated Biphenyls (PCBs): Environmental Impact, Biochemical and Toxic Responses, and Implications for Risk Assessment
1994
Equine Metabolic Syndrome
2010 Standout
The Pharmacokinetics of Vecuronium in Male and Female Patients
1998
Nonsteroidal Anti-Inflammatory Drugs in Perisurgical Pain Management
1995
Paresis Acquired in the Intensive Care Unit<SUBTITLE>A Prospective Multicenter Study</SUBTITLE>
2002 Standout
Review of the biology of quercetin and related bioflavonoids
1995 Standout
Concurrent daily carboplatin and accelerated hyperfractionated thoracic radiotherapy in locally advanced nonsmall cell lung cancer
1997
Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study
1993 Standout
Immune Functions in the Fisher Rat Fed Beluga Whale (Delphinapterus leucas) Blubber from the Contaminated St. Lawrence Estuary
1999
A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
1995 Standout
Human health implications of environmental contaminants in Arctic Canada: a review
1999 Standout
Developmental Pharmacology — Drug Disposition, Action, and Therapy in Infants and Children
2003 Standout
Pathophysiology and Management of Pulmonary Infections in Cystic Fibrosis
2003 Standout
The effect of rifampicin on norethisterone pharmacokinetics
1979
Noncompartmental Determination of the Steady‐State Volume of Distribution
1979
Introduction to pharmacokinetics: Aminoglycosides in cystic fibrosis as a prototype
1986
EDC-2: The Endocrine Society's Second Scientific Statement on Endocrine-Disrupting Chemicals
2015 Standout
Application of a Radiotelemetric System to Evaluate the Performance of Enteric Coated and Plain Aspirin Tablets
1986
Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells
1991 Standout
Drug delivery systems
1981
Antioxidant properties of phenolic compounds
1997 Standout
Effect of age and parenchymal liver disease on the disposition and elimination of chlordiazepoxide (Librium)
1978
Male reproductive health and environmental xenoestrogens.
1996 Standout
Prediction of Drug Absorption Using Multivariate Statistics
2000 Standout
THE FORMATION AND METABOLISM OF CYCLIC GMP*
1971 StandoutNobel
A toxicity and pharmacokinetic study in man of the hypoxic-cell radiosensitiser RSU-1069
1986
Pharmacokinetics, Excretion, and Mass Balance of Liposomal Amphotericin B (AmBisome) and Amphotericin B Deoxycholate in Humans
2002
Statistical estimations in pharmacokinetics
1974
Noncompartmental Determination of the Steady-State Volume of Distribution for Any Mode of Administration
1982 Standout
The application of statistical moment theory to the evaluation ofin vivo dissolution time and absorption time
1980 Standout
Mode of Action of Psychomotor Stimulant Drugs
1970
Role of Pharmacokinetics and Metabolism in Drug Discovery and Development
1997
Structure-pharmacokinetic relationships for misonidazole analogues in mice
1981
The Role of Chemistry in the Development of Boron Neutron Capture Therapy of Cancer
1993 Standout
Chemotherapy for advanced gastric cancer
2017 Standout
Effects of parathyroid hormone on plasma and urinary adenosine 3′,5′-monophosphate in man
1970 StandoutNobel
Barrier properties of the newborn infant's skin
1983 Standout
Cyclodextrin Drug Carrier Systems
1998 Standout
Secnidazole. A 5-nitroimidazole derivative with a long half-life.
1978
Pharmacokinetics of absorption, distribution and elimination of fenfluramine and its main metabolite in man
1972
Effects of glucagon on adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in human plasma and urine
1970 StandoutNobel
Pharmacokinetics of ampicillin and its prodrugs bacampicillin and pivampicillin in man
1979
Comparative Pharmacokinetics of Coumarin Anticoagulants IV
1968
Quinine pharmacokinetics and toxicity in cerebral and uncomplicated falciparum malaria
1982
Pharmacokinetics of metformin after intravenous and oral administration to man
1979
The effect of SBE4-β-CD on i.m. prednisolone pharmacokinetics and tissue damage in rabbits: Comparison to a co-solvent solution and a water-soluble prodrug
1995
Extravascular transport in normal and tumor tissues
1986
U.S. Medical Eligibility Criteria for Contraceptive Use, 2016
2016 Standout
Relationship Between Drug Concentration in Plasma or Serum and Amount of Drug in the Body
1969
Kinetic parameters and renal clearances of plasma adenosine 3′,5′-monophosphate and guanosine 3′,5′-monophosphate in man
1970 StandoutNobel
Cyclooxygenase in biology and disease
1998 Standout
Therapeutic Potential of Quercetin: New Insights and Perspectives for Human Health
2020 Standout
Pharmacokinetic Profile of Diazepam in Man following Single Intravenous and Oral and Chronic Oral Administrations
1973
Linear pharmacokinetic models and vanishing exponential terms: Implications in pharmacokinetics
1976
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Pharmacokinetic Profile of Sulfisoxazole following Intravenous, Intramuscular, and Oral Administration to Man
1972
Pharmacokinetics of Gentamicin in Children and Adults
1975
Disposition of quercetin in man after single oral and intravenous doses
1975
Guidelines for Treatment of Candidiasis
2004 Standout
Clinical and Microbiological Aspects ofTrichomonas vaginalis
1998 Standout
Application of Akaike's information criterion (AIC) in the evaluation of linear pharmacokinetic equations
1978 Standout
EXTRACELLULAR CYCLIC NUCLEOTIDES*
1971 StandoutNobel
Inhibition of ethanol-induced excitation in mice and rats by ?-methyl-p-tyrosine
1972 StandoutNobel
Effect of Mode of Administration on Drug Distribution in a Two-Compartment Open System
1969
Prescribed drugs containing nitrogen heterocycles: an overview
2020 Standout
Works of J.C.K. Loo being referenced
Effects of aroclor 1254® on hydrocortisone levels in adult rhesus monkeys (Macaca mulatta)
1989
Immunotoxicity studies of PCB (Aroclor 1254) in the adult rhesus (Macaca Mulatta) monkey — preliminary report
1989
Pharmacokinetic evaluation of betameth asone and its water soluble phosphate ester in humans
1981
Pharmacokinetics of pivampicillin and ampicillin in man
1974
Shortcomings in Pharmacokinetic Analysis by Conceiving the Body to Exhibit Properties of a Single Compartment
1968
Assessment of Pharmacokinetic Constants from Postinfusion Blood Curves Obtained after I.V. Infusion
1970
Analysis of prednisolone in plasma by high-performance liquid chromatography
1977
Dose-dependent pharmacokinetics of prednisone and prednisolone in man
1978
New Method for Calculating the Intrinsic Absorption Rate of Drugs
1968
Concept of a Volume of Distribution and Possible Errors in Evaluation of This Parameter
1968